The international explosion of mobile & digital health

28 September 2021 | 13:00 EDT | Online

Fresh approaches for managing content, culture and global markets

Join us to discuss what is the best approach to the requirements of the digital healthcare world while making the most of the innovation wave across pharma and devices.

The pandemic we’ve been living through has pushed digital transformation in all sectors and life sciences companies need to take advantage of this trend. But besides the need to ride the digital wave, you need to ensure that your online portals, mobile apps are ready for all different markets. How can you get ready for this? Join us next 28 of September to find out!


The international explosion of mobile & digital health

28 September 2021 | 13:00 EDT | Online

Meet the Speakers

Kathleen O’Brien

Kathleen O’Brien, Director of Business Development, Amplexor

Kathleen O’Brien is director of business development with Amplexor Life Sciences and a 17-year veteran of the translation industry. Kathleen has a background in linguistics and has held various roles in the translation business: vendor, project and account management, as well as new business development, giving her a unique perspective into both translation operations and how translation impacts the globalization needs of her clients in the pharmaceutical and medical device industries. She proactively collaborates with her life sciences client partners on a daily basis to help them set their globalization content strategies.

Leigh Ann Soltysiak

Leigh Ann Soltysiak, Founder, Principal, Silverleaf Consulting

Leigh Soltysiak has over 25 years of experience within the healthcare /life-sciences industry, specializing in commercialization /new product development, launch strategy and marketing/sales execution. She advises startup and established companies on how to achieve success throughout the critical product and brand developmental milestones: customer insights mining/research, problem/product ideation, value proposition creation, target product profile, market analytics, market development and access, global launch strategy, integrated marketing planning, strategic sales execution, life-cycle plan, portfolio planning, business development and more. 

Heather Reilly

Heather Reilly, Director, Quality Analytics, Janssen, Pharmaceutical Company of Johnson & Johnson

Heather Reilly is a disruptor and change agent with an exceptional and diverse 20+ year career in the pharmaceuticals, consumer and medical device industries. Her vision is to transform data into risk-based insights and to harness innovative tools to deliver proactive quality while driving top compliance. This is done by blending her passion, knowledge of science and ingenuity to profoundly change the trajectory of health for humanity. She has capitalized on being a 20-year veteran of Johnson and Johnson by leaning into different opportunities across its vast and diverse portfolio. Reilly brings her passion of encouraging young women to a STEM career in servicing the committee as a Board of Trustee to the Princeton-Blairstown Center. She holds a bachelor’s degree in chemistry and a master of science in quality systems management.